|1.||Garnero, Patrick: 4 articles (12/2011 - 01/2002)|
|2.||Radisky, Derek C: 3 articles (10/2011 - 07/2005)|
|3.||Biondi, Maria Luisa: 3 articles (03/2008 - 01/2002)|
|4.||Campbell, Megan N: 2 articles (05/2014 - 10/2011)|
|5.||Young, Scott K: 2 articles (05/2014 - 10/2011)|
|6.||Dolgonos, Lior: 2 articles (05/2014 - 10/2011)|
|7.||Zemans, Rachel L: 2 articles (05/2014 - 10/2011)|
|8.||Downey, Gregory P: 2 articles (05/2014 - 10/2011)|
|9.||Riches, David W H: 2 articles (05/2014 - 10/2011)|
|10.||McCulloch, Christopher A G: 2 articles (05/2014 - 10/2011)|
04/01/2012 - "Treating to target matrix metalloproteinase 3 normalisation together with disease activity score below 2.6 yields better effects than each alone in rheumatoid arthritis patients: T-4 Study."
03/01/1990 - "We identified the cells synthesizing stromelysin to be synovial cells in the synovial tissue from four biopsy cases with rheumatoid arthritis (RA) by in situ hybridization and immunohistochemical studies. "
03/01/2004 - "Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis."
04/01/2003 - "Possible role of shared epitope status in the relationship between matrix metalloproteinase 3 genotype and radiographic progression of rheumatoid arthritis: comment on the article by Constantin et al."
12/01/2000 - "To analyze the clinical significance of serial measurements of serum matrix metalloproteinase 3 (MMP-3) levels in relation to markers of disease activity and radiological progression in early rheumatoid arthritis (RA). "
12/01/1996 - "Following heat shock stimulation, the stromelysin 1 transcript was up-regulated in U87 MG astrocytoma cells. "
06/01/1989 - "3 h of heat shock at a lower temperature (42 degrees C) is also effective in inducing collagenase and stromelysin mRNAs. "
06/01/1989 - "Our data suggest that heat shock may be an additional mechanism whereby collagenase and stromelysin are increased during rheumatoid arthritis and perhaps in other chronic inflammatory stress conditions."
06/01/1989 - "In addition, all-trans-retinoic acid, added just before heat shock, prevents the increase in mRNAs for collagenase and stromelysin. "
06/01/1989 - "Heat shock of rabbit synovial fibroblasts increases expression of mRNAs for two metalloproteinases, collagenase and stromelysin."
10/20/1997 - "Our results suggest a novel role for beta 2-m in articular inflammation and destruction mediated by stromelysin in HAA."
06/01/1994 - "The stromelysin level in SF was thought to be a useful parameter of local joint involvement and that in serum of the severity of systemic joint inflammation."
07/01/1995 - "To evaluate the efficacy of stromelysin-1 (matrix metalloproteinase-3 [MMP-3]) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in serum as markers for joint inflammation in rheumatoid arthritis (RA). "
12/01/2000 - "These data suggest that genetic factors that predispose to reduced matrix remodeling (stromelysin 6A allele) and to increased inflammation (IL-6 G allele) combine to increase susceptibility for intima-media thickening in the carotid bifurcation, a predilection site for atherosclerosis."
05/01/2013 - "Surprisingly, ASIC-3(-/-) mice with CAIA demonstrated significantly increased joint inflammation, joint destruction, and expression of interleukin-6 (IL-6), matrix metalloproteinase 3 (MMP-3), and MMP-13 in joint tissue as compared to ASIC-3(+/+) mice. "
01/01/1991 - "Transin-expressing hepatocytes were largely localized in areas subsequently eliminated by necrosis due to CCl4 intoxication. "
06/01/1997 - "Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy."
08/01/2005 - "Treatment resulted in increased numbers of CD4 cells infiltrating the colonic lamina propria, increased interferon gamma (IFN-gamma) levels, and increased transcripts for tumour necrosis factor alpha (TNF-alpha) and matrix metalloproteinase 3 (MMP3). "
04/01/2010 - "Lipoma arborescens co-existing with psoriatic arthritis releases tumour necrosis factor alpha and matrix metalloproteinase 3."
10/01/1996 - "Medial femoral condyle were histologically processed, and the articular cartilage was stained for the presence of proteoglycans, stromelysin, tumor necrosis facto (TNF) alpha, and TNF receptors (p55 and p75). "
01/01/2011 - "There was no significant association between grade and expression of p53 and stromelysin in cancer tissue. "
01/01/2011 - "Subsequently, cancer tissue was processed, endolymphatic, intravascular and peritoneal invasion determined and CK-7, CK-20, stromelysin, Ki-67 and p53 expression evaluated. "
10/01/2004 - "Elevated expression of matrix metalloproteinase-3 (MMP-3/stromelysin-1) is associated with a variety of tumor types, although its in vivo functional role remains unclear. "
05/16/2003 - "Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: down-regulation of matrix metalloproteinase-3/-9/-14 and CD44."
08/01/2001 - "Loss of JunB activity enhances stromelysin 1 expression in a model of the epithelial-to-mesenchymal transition of mouse skin tumors."
|3.||Matrix Metalloproteinase 9 (Gelatinase B)
|4.||Messenger RNA (mRNA)
|5.||Matrix Metalloproteinase 1 (Interstitial Collagenase)
|6.||Matrix Metalloproteinase 2 (Gelatinase A)
|7.||Matrix Metalloproteinase 3 (Stromelysin 1)
|9.||Collagen Type IV (Type IV Collagen)
|2.||Exercise Therapy (Therapy, Exercise)
|5.||Heterologous Transplantation (Xenotransplantation)